Keyphrases
Cytotoxic Activity
100%
Epigenetics
100%
Thailandepsin A
100%
Small Molecules
100%
Histone Deacetylase Inhibitor (HDACi)
100%
Ovarian Cancer Screening
100%
Ovarian Cancer Cells
100%
FK228
61%
Cell Viability
30%
DNA Damage Response
23%
Ovarian Cancer
15%
Cytotoxic Effect
15%
Tubulin Acetylation
15%
Apoptosis
7%
Induced Apoptosis
7%
Protein Expression
7%
Western Blot
7%
Antitumor Effect
7%
Inhibitory Effect
7%
Caspase-3 Activation
7%
Target DNA
7%
Cell Apoptosis
7%
Drug Concentration
7%
Therapeutic Potential
7%
Romidepsin
7%
P-glycoprotein (P-gp)
7%
Minimal Impact
7%
New Treatment Options
7%
Cellular Viability
7%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
7%
Nanomolar Concentrations
7%
MTT Assay
7%
Biological Activity
7%
Immunofluorescence Assay
7%
Class I HDACs
7%
PARP Cleavage
7%
DNA Damage Response Pathway
7%
HDAC6 Inhibitor
7%
Glycoprotein Acetyls
7%
Medicine and Dentistry
Cytotoxicity
100%
Cancer Cell
100%
Cancer Therapy
100%
Ovarian Cancer
100%
Romidepsin
100%
Histone Deacetylase Inhibitor
100%
Cell Viability
55%
DNA Damage Response
44%
Programmed Cell Death
33%
Tubulin
22%
Acetylation
22%
Ovarian Cancer Cell Line
22%
Protein Expression
11%
In Vitro
11%
Cell Line
11%
Poly ADP Ribose Polymerase
11%
Caspase 3
11%
Histone Deacetylase 6
11%
Biological Activity
11%
Cell DNA
11%
ABC Transporter Subfamily B
11%
Immunofluorescence Test
11%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
11%
MTT Assay
11%
Western Blotting
11%
Pharmacology, Toxicology and Pharmaceutical Science
Preclinical Study
100%
Romidepsin
100%
Histone Deacetylase Inhibitor
100%
Ovary Cancer
100%
Cytotoxicity
100%
Cell Viability
44%
Tubulin
22%
Western Blot
11%
Drug Concentration
11%
P-Glycoprotein
11%
Caspase 3
11%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
11%
Biological Activity
11%
Histone Deacetylase 6
11%